C

Penumbra, Inc. PEN

$324.39 -$0.57-0.18% NYSE
Recommendation
Dividend Power Score
Day's Range
$323.88$325.33
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

PEN Rating

Reward
Risk

PEN Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

PEN Company Overview

Penumbra, Inc. is a global medical technology company focused on the development and commercialization of innovative devices for the treatment of life-threatening conditions. The company primarily operates in the medical devices and interventional healthcare industries, with a strong emphasis on neurovascular, vascular, and critical care interventions. Penumbra’s products are designed to address conditions such as ischemic stroke, pulmonary embolism, deep vein thrombosis, and other vascular disorders, serving hospitals, physicians, and interventional specialists worldwide.

Founded in 2004, Penumbra has evolved from a neurovascular-focused startup into a diversified interventional device company. Its growth has been driven by internally developed technologies, physician-led innovation, and expanding clinical indications for its platforms. The company is recognized for its aspiration-based thrombectomy technologies and its emphasis on rapid, minimally invasive treatment solutions that improve patient outcomes and procedural efficiency.

Data compiled by narrative technology. May contain errors.
Sector

PEN Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

PEN Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

PEN Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

PEN Price History

Loading...
52-Week Range73% of range
Current
$324.39
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

PEN Valuation

Market Cap
Market Cap Rank
#2,059
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

PEN Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

PEN Corporate Info

Phone Number
510 748 3200
Address
One Penumbra Place
Alameda, CA 94502
Country
Year Founded

PEN Filings

Filing Date
Thursday, July 30, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

PEN Headlines

10/1/2026 - Zacks Investment Research
9/29/2026 - Zacks Investment Research
9/11/2026 - Zacks Investment Research